Cite
HARVARD Citation
Poller, L. et al. (2013). Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal. Journal of thrombosis and haemostasis. 11 (6), pp. 1203-1205. [Online].